News

The US District Court has ruled in favor of Merck in two jointly related patent infringement suits. Merck general counsel and executive vice president Bruce Kuhlik said, "The

Arzerra (ofatumumab) is submitted for the approval to treat chronic lymphocytic leukemia (CLL). Genmab chief executive officer Jan van de Winkel said, "This marks another important achievement in

The products include low particulate carboys and bottles, manufactured from resins approved for medical applications, to store and transport biopharmaceuticals, culture media, bulk vaccines and other biotech materials.

Cholestor supplement can keep cholesterol ratios in balance naturally, claims the company. VitalMax Vitamins medical expert Mark Rosenberg said Cholestor helps put HDL and LDL into perfect ratio

Vyvanse is a prescription medicine currently approved in the US and Canada, as well as in Brazil under the name Venvanse, for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD).

The blinded, ascending, single dose study demonstrated that RG3039 was well tolerated at all doses administered and showed evidence of a dose-related drug response resulting in 90% inhibition

The study showed that levomilnacipran considerably reduced depression symptoms in MDD patients compared to placebo and further analyses of the data are ongoing. The companies expect to file

Hi-Tech is in the process of launching Lidocaine 5% Ointment, indicated for use as a local anesthetic, and the profits from the sale of the product will be

Alogliptin is a DPP-4 inhibitor that is being investigated in the US, as an adjunct to diet and exercise, for the treatment of type 2 diabetes. The FDA